Suppr超能文献

鞘内联合输注硫酸镁和吗啡对大鼠的抗伤害感受增强作用及耐受性减弱作用

Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.

作者信息

McCarthy R J, Kroin J S, Tuman K J, Penn R D, Ivankovich A D

机构信息

Department of Anesthesiology, Rush Medical College at Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.

出版信息

Anesth Analg. 1998 Apr;86(4):830-6. doi: 10.1097/00000539-199804000-00028.

Abstract

UNLABELLED

N-methyl-D-aspartate (NMDA) antagonists, such as MK801, delay the development of morphine tolerance. Magnesium, a noncompetitive NMDA antagonist, reduces postoperative morphine requirements. The present study was designed to evaluate the effects of intrathecal co-administration of magnesium sulfate with morphine on antinociceptive potentiation, tolerance, and naloxone-induced withdrawal signs. Magnesium sulfate (40-60 microg/h) co-administration for 7 days, similar to MK801 (10 nmol/h), prevented the decline in antinociceptive response compared with morphine (20 nmol/h). Magnesium sulfate (60 microg/h) produced no antinociception, but co-infused with morphine (1 nmol/h), it resulted in potentiated antinociception compared with morphine throughout the 7-day period. Probe morphine doses after 7-day infusions demonstrated a significantly greater 50% effective dose value for morphine 1 nmol/h (109.7 nmol) compared with saline (10.9 nmol), magnesium sulfate 60 microg/h (10.9 nmol), and magnesium sulfate 60 microg/h plus morphine 1 nmol/h (11.2 nmol), which indicates that magnesium had delayed morphine tolerance. Morphine withdrawal signs after naloxone administration were not altered by the co-infusion of magnesium sulfate. Cerebrospinal fluid magnesium levels after intrathecal magnesium sulfate (60 microg/h) for 2 days increased from 17.0 +/- 1.0 microg/mL to 41.4 +/- 23.6 microg/mL, although serum levels were unchanged. This study demonstrates antinociceptive potentiation and delay in the development of morphine tolerance by the intrathecal coinfusion of magnesium sulfate and morphine in the rat.

IMPLICATIONS

The addition of magnesium sulfate, an N-methyl-D-aspartate antagonist, to morphine in an intrathecal infusion provided better analgesia than morphine alone in normal rats. These results suggest that intrathecal administration of magnesium sulfate may be a useful adjunct to spinal morphine analgesia.

摘要

未标记

N-甲基-D-天冬氨酸(NMDA)拮抗剂,如MK801,可延缓吗啡耐受性的形成。镁作为一种非竞争性NMDA拮抗剂,可降低术后吗啡需求量。本研究旨在评估鞘内联合给予硫酸镁和吗啡对镇痛增强、耐受性及纳洛酮诱发的戒断症状的影响。与MK801(10 nmol/h)相似,硫酸镁(40 - 60 μg/h)联合给药7天,与吗啡(20 nmol/h)相比,可防止镇痛反应下降。硫酸镁(60 μg/h)本身无镇痛作用,但与吗啡(1 nmol/h)联合输注时,在整个7天期间与吗啡相比可增强镇痛作用。7天输注后探测吗啡剂量显示,与生理盐水(10.9 nmol)、硫酸镁60 μg/h(10.9 nmol)及硫酸镁60 μg/h加吗啡1 nmol/h(11.2 nmol)相比,吗啡1 nmol/h的50%有效剂量值(109.7 nmol)显著更高,这表明镁延缓了吗啡耐受性。硫酸镁联合输注未改变纳洛酮给药后吗啡的戒断症状。鞘内给予硫酸镁(60 μg/h)2天后,脑脊液镁水平从17.0±1.0 μg/mL升至41.4±23.6 μg/mL,而血清水平未变。本研究证明鞘内联合输注硫酸镁和吗啡可增强大鼠镇痛作用并延缓吗啡耐受性的形成。

启示

在鞘内输注中,向吗啡中添加N-甲基-D-天冬氨酸拮抗剂硫酸镁,在正常大鼠中比单独使用吗啡提供更好的镇痛效果。这些结果表明鞘内给予硫酸镁可能是脊髓吗啡镇痛的有用辅助手段。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验